menu
    • menu

    Company profile for Pathos

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pathos was borne from the belief that cancer is a collection of hundreds of rare diseases and can be best described by pathways accounting for the pathophysiology of patients. We license or co-develop clinical-stage therapeutics to ensure highly efficacious drugs are developed for the patients most likely to benefit and with significant unmet needs. Our patient selection strategies are optimized for the fastest path to approva...
    Pathos was borne from the belief that cancer is a collection of hundreds of rare diseases and can be best described by pathways accounting for the pathophysiology of patients. We license or co-develop clinical-stage therapeutics to ensure highly efficacious drugs are developed for the patients most likely to benefit and with significant unmet needs. Our patient selection strategies are optimized for the fastest path to approval to improve patient outcomes as quickly as possible. Our aim is ultimately to accelerate the translation of real-world data into breakthrough therapies for patients that need them most.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PathosUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Los Angeles, California
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pathos.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pathos AI's $365M series D to fund trial of Novo tumor drug
    Pathos AI's $365M series D to fund trial of Novo tumor drug

    15 May 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/pathos-ai-secures-365m-series-d-fund-trial-novo-nordisk-solid-tumor-drug

    FIERCE BIOTECH
    15 May 2025
    Share Share
    Pathos AI Appoints Iker Huerga as CEO for AI Drug Development
    Pathos AI Appoints Iker Huerga as CEO for AI Drug Development

    08 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/08/3077172/0/en/Pathos-AI-Appoints-Iker-Huerga-as-Chief-Executive-Officer-to-Lead-the-Next-Era-of-AI-Enabled-Drug-Development.html

    GLOBENEWSWIRE
    08 May 2025
    Share Share
    Pathos AI gets AZ funding as biotech plans to raise up to $400M
    Pathos AI gets AZ funding as biotech plans to raise up to $400M

    03 May 2025

    // ENDPTS

    https://endpts.com/pathos-ai-gets-astrazeneca-funding-as-biotech-plans-to-raise-up-to-400m/

    ENDPTS
    03 May 2025
    Share Share
    Tempus AI in line for $200M from AstraZeneca cancer model deal
    Tempus AI in line for $200M from AstraZeneca cancer model deal

    23 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/tempus-ai-line-200m-astrazeneca-pathos-deal-develop-cancer-model

    FIERCE BIOTECH
    23 Apr 2025
    Share Share
    Pathos AI Closes $62M Series C to Accelerate Drug Development
    Pathos AI Closes $62M Series C to Accelerate Drug Development

    29 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/29/2970762/0/en/Pathos-AI-Closes-62M-Oversubscribed-Series-C-Round-of-Financing-to-Accelerate-its-Platform-Approach-to-Drug-Development.html

    GLOBENEWSWIRE
    29 Oct 2024
    Share Share
    Pathos Secures Worldwide License For Phase 2-ready PRMT5 Inhibitor
    Pathos Secures Worldwide License For Phase 2-ready PRMT5 Inhibitor

    15 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/15/2930866/0/en/Pathos-Expands-Pipeline-With-Worldwide-License-of-Phase-2-ready-Brain-penetrant-PRMT5-Inhibitor.html

    GLOBENEWSWIRE
    15 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search